Gateway Investment Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33M Buy
85,451
+210
+0.2% +$77.9K 0.33% 71
2026
Q1
$25M Sell
85,241
-14,549
-15% -$4.78M 0.28% 84
2025
Q4
$35M Sell
99,790
-158
-0.2% -$53.4K 0.33% 67
2025
Q3
$32.3M Buy
99,948
+979
+1% +$304K 0.31% 71
2025
Q2
$38.5M Sell
98,969
-458
-0.5% -$184K 0.42% 60
2025
Q1
$43.2M Buy
99,427
+230
+0.2% +$92.3K 0.5% 52
2024
Q4
$36.6M Sell
99,197
-1,659
-2% -$694K 0.41% 64
2024
Q3
$52.4M Sell
100,856
-116
-0.1% -$62K 0.58% 39
2024
Q2
$54.7M Buy
100,972
+1,228
+1% +$649K 0.62% 36
2024
Q1
$51.7M Buy
99,744
+94
+0.1% +$46.7K 0.59% 42
2023
Q4
$47M Sell
99,650
-73
-0.1% -$33.8K 0.55% 46
2023
Q3
$43.4M Sell
99,723
-69
-0.1% -$31.3K 0.55% 46
2023
Q2
$44.3M Sell
99,792
-193
-0.2% -$89K 0.52% 49
2023
Q1
$46M Sell
99,985
-6,563
-6% -$3.12M 0.56% 47
2022
Q4
$54.7M Buy
106,548
+842
+0.8% +$428K 0.68% 35
2022
Q3
$48M Sell
105,706
-805
-0.8% -$385K 0.6% 41
2022
Q2
$51.4M Buy
106,511
+218
+0.2% +$108K 0.58% 43
2022
Q1
$52.2M Buy
106,293
+651
+0.6% +$298K 0.52% 53
2021
Q4
$49M Buy
105,642
+245
+0.2% +$103K 0.47% 56
2021
Q3
$39.3M Sell
105,397
-43
-0% -$16.3K 0.41% 68
2021
Q2
$40.3M Sell
105,440
-394
-0.4% -$151K 0.41% 64
2021
Q1
$38M Buy
105,834
+55
+0.1% +$17.7K 0.41% 65
2020
Q4
$34M Sell
105,779
-20,267
-16% -$6.22M 0.37% 75
2020
Q3
$33.9M Sell
126,046
-7,986
-6% -$2.15M 0.39% 67
2020
Q2
$35.2M Sell
134,032
-5,141
-4% -$1.37M 0.42% 63
2020
Q1
$31.6M Sell
139,173
-5,623
-4% -$1.53M 0.39% 69
2019
Q4
$43.7M Sell
144,796
-2,154
-1% -$593K 0.43% 63
2019
Q3
$35.3M Sell
146,950
-14,192
-9% -$3.89M 0.36% 77
2019
Q2
$45.5M Sell
161,142
-11,412
-7% -$3.12M 0.41% 60
2019
Q1
$49.5M Sell
172,554
-33,561
-16% -$9.71M 0.44% 60
2018
Q4
$54.1M Buy
206,115
+17,236
+9% +$4.74M 0.51% 51
2018
Q3
$51.8M Sell
188,879
-6,823
-3% -$1.77M 0.43% 62
2018
Q2
$46.6M Sell
195,702
-1,405
-0.7% -$325K 0.41% 67
2018
Q1
$43.3M Sell
197,107
-4,316
-2% -$1.01M 0.38% 75
2017
Q4
$45.3M Sell
201,423
-23,001
-10% -$4.9M 0.39% 75
2017
Q3
$42.6M Sell
224,424
-5,461
-2% -$1.04M 0.37% 79
2017
Q2
$43.2M Sell
229,885
-791
-0.3% -$142K 0.39% 76
2017
Q1
$38.1M Sell
230,676
-11,621
-5% -$1.85M 0.35% 83
2016
Q4
$34.8M Sell
242,297
-8,993
-4% -$1.2M 0.33% 90
2016
Q3
$31.5M Sell
251,290
-11,260
-4% -$1.45M 0.28% 99
2016
Q2
$34.5M Buy
262,550
+399
+0.2% +$54.6K 0.3% 93
2016
Q1
$36.4M Buy
262,151
+6,048
+2% +$808K 0.32% 92
2015
Q4
$35.7M Sell
256,103
-11,771
-4% -$1.62M 0.3% 89
2015
Q3
$37.5M Sell
267,874
-2,193
-0.8% -$330K 0.33% 83
2015
Q2
$44.3M Buy
270,067
+11,446
+4% +$1.83M 0.37% 78
2015
Q1
$39.9M Buy
258,621
+255
+0.1% +$36.3K 0.33% 88
2014
Q4
$32.5M Sell
258,366
-10,215
-4% -$1.26M 0.27% 106
2014
Q3
$32.1M Sell
268,581
-7,625
-3% -$875K 0.25% 102
2014
Q2
$29.7M Buy
276,206
+962
+0.3% +$99.1K 0.23% 118
2014
Q1
$27.4M Sell
275,244
-18,305
-6% -$1.66M 0.22% 124
2013
Q4
$27.1M Sell
293,549
-3,059
-1% -$272K 0.22% 121
2013
Q3
$24.8M Sell
296,608
-6,853
-2% -$587K 0.21% 120
2013
Q2
$24.8M Buy
+303,461
New +$22.7M 0.22% 118

Other funds holding ELV

Gateway Investment Advisers's ELV Position: Q2 2026 in Review

Gateway Investment Advisers increased its Elevance Health (ELV) stake by 0.25% in Q2 2026, buying an estimated $77.9K and bringing the position to 85,451 shares worth $33M. The position accounts for 0.33% of the portfolio, ranked #71.

Gateway Investment Advisers first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.7M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Gateway Investment Advisers held 85,451 shares of Elevance Health worth $33M as of Q2 2026.
  • Gateway Investment Advisers bought 210 Elevance Health shares in Q2 2026, an estimated $77.9K.
  • Elevance Health made up 0.33% of Gateway Investment Advisers's portfolio in Q2 2026, its #71 holding.
  • Gateway Investment Advisers first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Elevance Health position peaked at $54.7M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.